Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
Series D Preferred Stock [Member]
Common Stock [Member]
At-the-market Offering [Member]
Series D Preferred Stock [Member]
Common Stock [Member]
Exercise of Warrants [Member]
Series D Preferred Stock [Member]
Common Stock [Member]
Series E Preferred Stock [Member]
Additional Paid-in Capital [Member]
At-the-market Offering [Member]
Series E Preferred Stock [Member]
Additional Paid-in Capital [Member]
Exercise of Warrants [Member]
Series E Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series E Preferred Stock [Member]
Retained Earnings [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Settlement of Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Series C Preferred Stock [Member]
Additional Paid-in Capital [Member]
Settlement of Preferred Stock [Member]
Series C Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series C Preferred Stock [Member]
Settlement of Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
At-the-market Offering [Member]
Common Stock [Member]
Exercise of Warrants [Member]
Common Stock [Member]
Cashless Exercise of Warrants [Member]
Common Stock [Member]
Cashless Exercise of Options [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Trek Therapeutics [Member]
Additional Paid-in Capital [Member]
At-the-market Offering [Member]
Additional Paid-in Capital [Member]
Exercise of Warrants [Member]
Additional Paid-in Capital [Member]
Cashless Exercise of Warrants [Member]
Additional Paid-in Capital [Member]
Cashless Exercise of Options [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Trek Therapeutics [Member]
Noncontrolling Interest [Member]
Receivables from Stockholder [Member]
Subscription Arrangement [Member]
Receivables from Stockholder [Member]
Trek Therapeutics [Member]
At-the-market Offering [Member]
Exercise of Warrants [Member]
Subscription Arrangement [Member]
Cashless Exercise of Options [Member]
Total
Balance at Dec. 31, 2018                                   $ 16,869           $ 74,039,341 $ (70,731,941)                   $ 3,324,269
Balance (in Shares) at Dec. 31, 2018                                   16,868,783                                  
Sale of common stock                                   $ 2,155           8,617,123                     8,619,278
Sale of common stock (in Shares)                                   2,155,127                                  
Common stock issued for services                                   $ 973           5,802,455                     5,803,428
Common stock issued for services (in Shares)                                   973,317                                  
Common stock issued upon conversion of preferred stock and accrued dividends               $ 21 $ 69 $ 139,571 $ 259,931 $ 139,592 $ 260,000                                            
Common stock issued upon conversion of preferred stock and accrued dividends (in Shares)               21,379 69,335                                                    
Sale of subsidiary shares to non-controlling interest                                               3,268,434     $ 426,212 $ 501,000         $ 501,000   3,694,646
Change in fair value of modified options                                               666,062                     666,062
Common stock issued upon exercise of options                                 $ 39 $ 98         $ (39) 465,100                     465,198
Common stock issued upon exercise of options (in Shares)                                 38,687 97,500                                  
Common stock issued upon exercise of warrants                             $ 1,563 $ 162         $ 6,353,307 $ (162)                   $ 6,354,870      
Common stock issued upon exercise of warrants (in Shares)                             1,562,896 161,986                                      
Stock based compensation                                   $ 83           1,892,775                     1,892,858
Stock based compensation (in Shares)                                   83,332                                  
Preferred Stock dividend                                               (20,286)                     (20,286)
Net loss                                                 (19,262,618)   (20,538)               (19,283,156)
Balance at Sep. 30, 2019                                   $ 22,032           101,483,612 (89,994,559)   405,674   $ 501,000           12,417,759
Balance (in Shares) at Sep. 30, 2019                                   22,032,342                                  
Balance at Jun. 30, 2019                                   $ 21,151           94,494,972 (84,551,093)                   9,965,030
Balance (in Shares) at Jun. 30, 2019                                   21,151,134                                  
Common stock issued for services                                   $ 413           1,196,215                     1,196,628
Common stock issued for services (in Shares)                                   413,317                                  
Sale of subsidiary shares to non-controlling interest                                               3,268,434     426,212 $ 501,000         $ 501,000   3,694,646
Common stock issued upon exercise of options                                   $ 4           20,356                     20,360
Common stock issued upon exercise of options (in Shares)                                   4,000                                  
Common stock issued upon exercise of warrants                             $ 433 $ 1         1,735,950 (1)                   1,736,383      
Common stock issued upon exercise of warrants (in Shares)                             432,867 1,024                                      
Stock based compensation                                   $ 30           772,563                     772,593
Stock based compensation (in Shares)                                   30,000                                  
Preferred Stock dividend                                               (4,877)                     (4,877)
Net loss                                                 (5,443,466)   (20,538)               (5,464,004)
Balance at Sep. 30, 2019                                   $ 22,032           101,483,612 (89,994,559)   405,674   $ 501,000           12,417,759
Balance (in Shares) at Sep. 30, 2019                                   22,032,342                                  
Balance at Dec. 31, 2019                                   $ 23,323           115,910,058 (104,786,769)   514,828               $ 11,661,440
Balance (in Shares) at Dec. 31, 2019                                   23,323,087                                 23,323,087
Sale of common stock                           $ 150       $ 4,688   $ 1,001,613       25,209,623             $ 1,001,763       $ 25,214,311
Sale of common stock (in Shares)                           150,000       4,687,500                                  
Common stock issued for services                                   $ 503           3,550,401                     $ 3,550,904
Common stock issued for services (in Shares)                                   503,038                                 503,038
Fair value of subsidiary shares issued to acquire research and development                                     $ 2,439,139         1,051,309   $ 735,411 248,486     $ 3,174,550         $ 1,299,795
Common stock issued upon conversion of preferred stock and accrued dividends               $ 16 $ 29 $ 70,325 $ 109,971 $ 70,341 $ 110,000                                            
Common stock issued upon conversion of preferred stock and accrued dividends (in Shares)               15,516 29,334                                                    
Sale of subsidiary shares to non-controlling interest                                               7,124,366   $ 983,897 3,467,709               10,592,075
Common stock issued upon exercise of options                                 $ 161 $ 586         $ (161) 2,721,426                     $ 2,722,012
Common stock issued upon exercise of options (in Shares)                                 160,743 586,825                               616,398 1,203,223
Common stock issued upon exercise of warrants                             $ 430 $ 13         $ 1,666,065 $ (13)                   1,666,495      
Common stock issued upon exercise of warrants (in Shares)                             429,979 12,840                                      
Stock based compensation                                   $ 219           14,385,910     2,636,298               $ 17,022,427
Stock based compensation (in Shares)                                   219,334                                  
Preferred Stock dividend                                               (11,698)                     (11,698)
Net loss                                                 (41,925,704)   (6,282,420)               (48,208,124)
Balance at Sep. 30, 2020     $ 30,118     $ 175,228,334 $ (146,712,473)                     $ 30,118           175,228,334 (146,712,473)   1,320,312               $ 29,866,291
Balance (in Shares) at Sep. 30, 2020     30,118,196                             30,118,196                                 30,118,196
Balance at Jun. 30, 2020     $ 29,127     168,499,417 (135,310,614)                                       2,793,950               $ 36,011,880
Balance (in Shares) at Jun. 30, 2020     29,126,663                                                                
Sale of common stock $ 150     $ 1,001,613                                                     $ 1,001,763        
Sale of common stock (in Shares) 150,000                                                                    
Common stock issued for services     $ 488     3,442,142                                                         3,442,630
Common stock issued for services (in Shares)     488,000                                                                
Common stock issued upon exercise of options     $ 108     492,424                                                         492,532
Common stock issued upon exercise of options (in Shares)     108,374                                                                
Common stock issued upon exercise of warrants   $ 160     $ 632,039                                                     $ 632,199      
Common stock issued upon exercise of warrants (in Shares)   160,159                                                                  
Stock based compensation     $ 85     1,163,080                                         222,944               1,386,109
Stock based compensation (in Shares)     85,000                                                                
Preferred Stock dividend           (2,381)                                                         (2,381)
Net loss             (11,401,859)                                       (1,696,582)               (13,098,441)
Balance at Sep. 30, 2020     $ 30,118     $ 175,228,334 $ (146,712,473)                     $ 30,118           $ 175,228,334 $ (146,712,473)   $ 1,320,312               $ 29,866,291
Balance (in Shares) at Sep. 30, 2020     30,118,196                             30,118,196                                 30,118,196